Cita APA

López-Márquez, A., Martínez Pizarro, A., Pérez González, M. B., Richard Rodríguez, E. M., & Ruiz Desviat, L. (2022). Modeling Splicing Variants Amenable to Antisense Therapy by Use of CRISPR-Cas9-Based Gene Editing in HepG2 Cells.

Citación estilo Chicago

López-Márquez, Arístides, Ainhoa Martínez Pizarro, María Belén Pérez González, Eva María Richard Rodríguez, y Lourdes Ruiz Desviat. Modeling Splicing Variants Amenable to Antisense Therapy By Use of CRISPR-Cas9-Based Gene Editing in HepG2 Cells. 2022.

Cita MLA

López-Márquez, Arístides, et al. Modeling Splicing Variants Amenable to Antisense Therapy By Use of CRISPR-Cas9-Based Gene Editing in HepG2 Cells. 2022.